Clinical trials established this schedule because tirzepatide has a long half-life, meaning it stays active in your system for several days after injection
Letters to JMG
With over half of adults in Europe living with overweight or obesity, understanding who may benefit most from interventions that encourage adherence is essential to improving treatment use and subsequent health outcomes and quality of life. Limits of What the Data Reveals Despite the important findings, the authors acknowledge several limitations of the study, including the fact that anthropometric measures such as the exact BMI are not generally available in Danish health registries, and they could not assess individual-level income, insurance coverage, or out-of-pocket pay, which could partially affect the conclusions
Guanmaitong granule attenuates atherosclerosis by inhibiting inflammatory immune response in apoE(-/-) mice fed high-fat diet
Some studies have suggested that stimulant medications can lead to a slight decrease in growth velocity, resulting in a temporary delay in height and weight gain during the first few years of treatment
Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation